Plasma melatonin is reduced in Huntington's disease-Reference-Cited by-同舟云学术

Plasma melatonin is reduced in Huntington's disease

Published:2014-08-27 Issue:12 Volume:29 Page:1511-1515
ISSN:0885-3185
Container-title:Movement Disorders
language:en
Short-container-title:Mov Disord.

Author:

Kalliolia Eirini¹,Silajdžić Edina²,Nambron Rajasree¹,Hill Nathan R.³,Doshi Anisha¹,Frost Chris⁴,Watt Hilary⁵,Hindmarsh Peter⁶,Björkqvist Maria²,Warner Thomas T.¹

Affiliation:

1. Reta Lila Weston Institute of Neurological StudiesDepartment of Molecular NeurosciencesUCL Institute of NeurologyLondon UK

2. Brain Disease Biomarker UnitDepartment of Experimental Medical ScienceWallenberg Neuroscience CentreLund UniversityLund Sweden

3. Nuffield Department of Primary Care Health SciencesUniversity of OxfordOxford UK

4. Department of Medical StatisticsLondon School of Hygiene and Tropical MedicineLondon UK

5. Department of Public Health and Primary CareImperial CollegeLondon UK

6. Developmental Endocrinology Research GroupUCL Institute of Child HealthLondon UK

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mds.26003

Reference24 articles.

1. A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

2. Beyond the brain: widespread pathology in Huntington's disease

3. Identifying sleep disturbances in Huntington’s disease using a simple disease-focused questionnaire

4. Daytime somnolence and nocturnal sleep disturbances in Huntington disease

5. Rapid Eye Movement Sleep Disturbances in Huntington Disease

Cited by 92 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sleep fragmentation despite intact rest-activity patterns in premanifest Huntington's disease: An actigraphy study;Sleep Medicine;2024-12

2. Circadian Interventions in Preclinical Models of Huntington’s Disease: A Narrative Review;Biomedicines;2024-08-06

3. The mechanisms of mitochondrial abnormalities that contribute to sleep disorders and related neurodegenerative diseases;Ageing Research Reviews;2024-06

4. Physiological Benefits of Phytomelatonin and the Prospects for it as a Nutraceutical: A Comprehensive Review;J BIOL REG HOMEOS AG;2024

5. Modulation of the Circadian Rhythm and Oxidative Stress as Molecular Targets to Improve Vascular Dementia: A Pharmacological Perspective;International Journal of Molecular Sciences;2024-04-16